Faster global financial news!
Johnson & Johnson MedTech Chairman Tim Schmid: Confident in High-End Growth, Cardiovascular to Be Largest Business by Q1 2027
Johnson & Johnson (JNJ) MedTech Chairman Tim Schmid stated the company is confident in achieving the high end of its 5% to 7% operational market-growth range for 2022-2027. He highlighted a portfolio shift towards cardiovascular products, which are expected to become the company's largest and fastest-growing MedTech business by the first quarter of next year, driven by acquisitions like Abiomed and Shockwave.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Source：Yahoo财经 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
Previous: Optical Cable (OCC) Q3 sales rose 22% to $24.3M, net income $1.9M ($0.21/share), driven by strong demand in enterprise, data center and specialty markets, despite supply constraints.
|
Next: Johnson & Johnson Plans Orthopedics Business Separation by Mid-2027, OTTAVA Surgical Robot Showing Positive Feedback
24H Trending
-
1
U.S. Treasury Sanctions Chinese-Language Cyber-Scam Hub Xinbi Guarantee
-
2
24/7 Wall St. Initiates Marvell Technology (MRVL) with Buy Rating, Sets Price Target at $281.53
-
3
MOL Chairman: Violent Yen Fluctuations Could Lead to Global Market "Chaos," Outlook for Strait of Hormuz Shipping Recovery Pessimistic
-
4
US-Iran Conflict Escalates: Iran Claims Attacks on US Vessels and Oil Tankers, Brent Crude Nears $100/Barrel
-
5
Chinese energy firms, including Sungrow and EVE Energy, warn policy volatility complicates long-term overseas expansion amid geopolitical risks
-
6
Iran eases currency rules to bypass US sanctions with crypto, per report
-
7
India's Manipur State Pledges to Complete Border Fencing with Myanmar by 2028
-
8
Dollar Nears Seven-Month Low as Yen Rallies; Traders Focus on US Buybacks and Inflation Data This Week
-
9
ING Chief Economist Blom Says One ECB Rate Hike 'Could Be Enough'
-
10
GINU Coin: A Multifaceted Analysis of GiveWell Inu, Green Shiba Inu, and Genie Inu's Trading Status
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
